Journal article icon

Journal article

Innovation translates into antidepressant effectiveness.

Abstract:

Unipolar depression is a major cause of disability in developed societies. There is significant unmet need because existing treatments are neither as effective nor as free of adverse effects as we would hope. Agomelatine is a new antidepressant with a novel profile of pharmacological action. Its efficacy in major depression has been reported in short-term placebo-controlled trials and in direct head-to-head comparison with existing products. The pooling of data from the agomelatine short-term...

Expand abstract

Actions


Access Document


Publisher copy:
10.1177/0269881108092592

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Psychiatry
Role:
Author
Journal:
Journal of psychopharmacology (Oxford, England)
Volume:
22
Issue:
7 Suppl
Pages:
9-12
Publication date:
2008-09-01
DOI:
EISSN:
1461-7285
ISSN:
0269-8811
Source identifiers:
98017

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP